Skip to main content

Table 1 Scale assessments

From: N-acetylcysteine as add-on to antidepressant medication in therapy refractory major depressive disorder patients with increased inflammatory activity: study protocol of a double-blind randomized placebo-controlled trial

Scale 1 HAMD-17 Self-rating scale for depressive symptoms
Scale 2 IDS-SR Self-rated inventory for depressive symptoms
BAI Self-reported inventory for anxious symptoms
CSI A list for somatic items
WHODAS-II To assess functioning
MoCA To assess cognition
Scale 3 DM-TRD To measure treatment resistance